ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma

Yan, Xiuwei; Wang, Nan; Dong, Jiawei; Wang, Fang; Zhang, Jiheng; Hu, Xueyan; Zhao, Hongtao; Gao, Xin; Liu, Zhihui*; Li, Yongzhe*; Hu, Shaoshan*哈尔滨医科大学
Frontiers in Molecular Biosciences2022-8-17DOI: 10.3389/fmolb.2022.966843
10被引14阅读
引用收藏
分享

摘要

Cuproptosis is a new type of cell death that is associated with mitochondrial respiration of the tricarboxylic acid cycle. Previous studies showed that long non-coding RNAs (lncRNAs) regulated low-grade glioma (LGG) progression. However, the potential applications of cuproptosis-related lncRNAs (CRLs) in LGG were not explored. A comprehensive analysis was performed in The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) cohorts. We first screened two distinct cuproptosis subtypes based on prognostic CRLs using consensus clustering. To facilitate individualized survival prediction in LGG, we constructed a prognostic signature (including CRNDE, HAR1A, and FAM181A-AS1) in the TCGA dataset. The prognostic signature exhibited excellent predictive ability and reliability, which was validated in the CGGA_325 and CGGA_693 datasets. Notably, patients in the high-risk group had increased immune cell infiltration and expression of immune checkpoints, which indicated that they may benefit more from immune checkpoint blockade (ICB) therapy. Finally, the prognostic signature screened the population with sensitivity to chemotherapy and ICB therapy. In summary, this study initially explored the mechanism of CRLs in LGG and provides some insights into chemotherapy and ICB therapy of LGG.

学科与关键词

关键词
cuproptosislncRNAsprognosislow-grade gliomaimmune checkpoint blockadechemotherapy
相关
加载中…
  • Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas
    Huang, Hao; Lv, Zhonghua; Yang, Longkun; Zhang, Xing; Deng, Ying; Huang, Zhicong; Bi, Haoran; Sun, Xizhuo; Zhang, Ming; Hu, Dongsheng; Liang, Hongsheng*; Hu, Fulan*Journal of Cancer Research and Clinical Oncology, 2023, 149(13): 11499-11515.
  • Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
    Jiang, Zi-Rong; Yang, Lin-Hui; Jin, Liang-Zi; Yi, Li-Mu; Bing, Ping-Ping; Zhou, Jun*; Yang, Jia-Sheng*Frontiers in Oncology, 2022, 12: 988680.被引 25
  • The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
    Zhang, Lishuo; Di, Longjiang; Liu, Jinhui; Lei, Xianli; Gu, Maoli; Zhang, Wenjing*; Wang, Yufu*Frontiers in Genetics, 2023, 14: 1039813.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Molecular Biosciences
发表日期
2022-08-17
卷期
第 9 卷
页码
966843
DOI
10.3389/fmolb.2022.966843
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Talent Introduction Project of Zhejiang Provincial People's Hospital [61575058]; [C-2021-QDJJ03-01]

作者

  • Y

    Yan, Xiuwei (第一作者)

    zhejiang prov peoples hosp

  • W

    Wang, Nan

    zhejiang prov peoples hosp

查看全部 11 位作者收起作者
  • D

    Dong, Jiawei

    zhejiang prov peoples hosp

  • W

    Wang, Fang

    zhejiang prov peoples hosp

  • Z

    Zhang, Jiheng

    zhejiang prov peoples hosp

  • H

    Hu, Xueyan

    zhejiang prov peoples hosp

  • Z

    Zhao, Hongtao

    zhejiang prov peoples hosp

  • G

    Gao, Xin

    zhejiang prov peoples hosp

  • L

    Liu, Zhihui (通讯)

    zhejiang prov peoples hosp

  • L

    Li, Yongzhe (通讯)

    2 · harbin med univ

  • H

    Hu, Shaoshan (通讯)

    zhejiang prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417